The scientific scope outlined by the society is unusually broad, reflecting how much the discipline has changed since the first annual meeting. According to the announcement, ISSCR 2027 will span breakthroughs in basic biology, advances in disease modeling and drug discovery, and new clinical data on cell-based therapies, with artificial intelligence described as an accelerating force across all three domains. That framing captures a genuine shift in the research landscape. Stem cell science is no longer confined to studies of pluripotency and differentiation; it now encompasses sophisticated organoid and tissue-engineered models of human development, engineering approaches to building biological systems, and a growing pipeline of cell and gene therapies that are producing clinical results in areas ranging from blood disorders to neurological disease. The meeting program is designed to showcase advances across this entire spectrum, from fundamental discoveries about how human tissues form to the engineering of new biological platforms and the evaluation of emerging therapies in patients.

Leadership of the meeting reflects its international character. ISSCR President Lorenz Studer, M.D., founding director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center in the United States, will preside over the Annual Meeting. Studer is widely known for his work on deriving dopamine-producing neurons from stem cells, research that has underpinned clinical efforts to treat Parkinson’s disease with cell replacement therapy. The scientific program itself will be led by two co-chairs drawn from different sides of the Atlantic and different methodological traditions: Viviane Tabar, M.D., of Memorial Sloan Kettering Cancer Center, and Matthias P. Lutolf, Ph.D., of the École Polytechnique Fédérale de Lausanne in Switzerland. Tabar’s background spans neurosurgery and stem cell-based approaches to nervous system disease, while Lutolf is recognized for pioneering work in organoids, engineered stem cell niches, and the microenvironmental cues that control tissue formation. The pairing signals a program intended to bridge clinical translation and fundamental bioengineering.

The structure of the scientific program will combine several formats that have become hallmarks of the meeting. Invited presentations will feature pioneering research from leaders in the field, while a substantial share of the platform presentations will be selected directly from submitted abstracts, a mechanism that gives early career researchers and scientists from less represented institutions a route onto the main program. Interactive poster sessions will run alongside these talks, and the society emphasizes opportunities for collaboration across academia, industry, and clinical research as a central purpose of the gathering. In practice, the meeting serves as the point in the calendar where a graduate student presenting a new organoid protocol can share a poster hall with a biotech executive scouting licensing opportunities and a clinician reporting results from an early phase trial, and the society has built explicit mechanisms to encourage exactly those encounters.

Complementing the scientific sessions, the Exhibit and Poster Hall will spotlight the technological infrastructure that increasingly defines modern stem cell research. The announcement highlights innovations in laboratory automation, advanced imaging, computational technologies, and cell manufacturing as focal points of the exhibition. Each of these areas has become critical to the field’s progress. Automation and robotics are enabling the reproducible, large-scale culture of stem cell lines that manual methods cannot achieve. Advanced imaging allows researchers to track cell fate and tissue morphogenesis in living systems with unprecedented resolution. Computational tools, increasingly augmented by machine learning, are being used to analyze the massive single-cell and spatial datasets that stem cell biology now routinely generates. Cell manufacturing, meanwhile, sits at the heart of the translational challenge: turning a laboratory protocol into a consistent, quality-controlled product suitable for clinical use. By connecting researchers directly with the companies and expertise behind these technologies, the society aims to shorten the distance between discovery and application.

The society has opened several distinct participation pathways, each with its own deadline, and together they reveal how the meeting is being shaped. The most consequential for most attendees is the abstract submission process, which closes on 27 January 2027. Researchers at all career stages are invited to submit their latest findings for consideration as oral or poster presentations, and travel awards are available to ISSCR student and postdoctoral members who submit abstracts, a measure designed to reduce the financial barriers that can keep young scientists from attending international meetings. Given that platform talks selected from abstracts are among the most visible slots at the meeting, the January deadline effectively functions as the first competitive gate of ISSCR 2027, and the society is encouraging submissions across the full breadth of the field rather than restricting them to particular themes.

Early career investigators have additional routes into the meeting’s organization. Applications to become ISSCR 2027 Ambassadors close on 23 October 2026, an unusually early deadline that reflects the ambassador program’s role in outreach and community engagement in the months before the meeting convenes. Ambassadors represent and engage the global stem cell research community in the run-up to the event, extending the meeting’s reach to regions and networks that might otherwise be underrepresented. Student and postdoctoral members can also propose Science Spotlight sessions, with proposals due on 27 January 2027, the same day as the abstract deadline. This mechanism hands junior researchers genuine agenda-setting power, allowing them to highlight emerging research areas, innovative approaches, and new developments that the formal program committee might not otherwise feature. It is a notable inversion of the traditional conference hierarchy, in which program content flows almost entirely from senior committees and invited speakers.

The society has also built in practical support and informal networking structures that acknowledge the realities of attending a four-day international meeting. Eligible ISSCR members can apply for Child and Dependent Care Grants to help offset the costs of care associated with attending in person; applications are due by 10 March 2027, and awards are distributed on a first-come, first-served basis, a detail that effectively rewards early planning. Researchers with shared scientific interests can organize Meet-Up Hubs, informal gatherings held in the Exhibit and Poster Hall, with a deadline of 19 April 2027 for proposals. Finally, the meeting will offer one-on-one partnering, a scheduling service that lets attendees arrange face-to-face meetings with researchers, industry representatives, and potential collaborators to explore scientific partnerships, investments, licensing opportunities, and new ventures. For translational labs and startup-minded investigators, this matchmaking layer is often cited as one of the meeting’s most valuable functions, since it converts a crowded congress into a structured series of targeted conversations.

The choice of San Francisco as host city reinforces the meeting’s translational ambitions. The Bay Area concentrates an exceptional density of academic stem cell research, biotechnology companies, cell therapy developers, and computational biology expertise, and the region has historically been a hub for both the scientific and commercial sides of regenerative medicine. Holding the twenty-fifth anniversary meeting at Moscone West places the global stem cell community at the intersection of those communities. As the announcement puts the matter, ISSCR 2027 will celebrate the legacy of twenty-five years of annual meetings while looking ahead to the discoveries, technologies, and collaborations that will define the future of the field and of human health. Registration and abstract submissions are now open through the meeting’s official site, and with abstracts due in late January 2027, researchers hoping to present their work at the Global Stem Cell Event face a timeline that begins now.

Subject of Research: Registration and abstract submissions for the ISSCR 2027 Annual Meeting on stem cell science and regenerative medicine

Article Title: ISSCR 2027 Annual Meeting opens registration and abstract submissions

Article References: ISSCR 2027 Annual Meeting opens registration and abstract submissions. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: ISSCR, stem cell research, annual meeting, regenerative medicine, abstract submissions, San Francisco, cell therapy, organoids, artificial intelligence, disease modeling, cell manufacturing, early career researchers